US Health and Human Services Secretary Robert F. Kennedy Jr. attacks scientific literature with censorship to push MAHA ...
The products are far from a proven sleep treatment.
Americans love working from home. Does it love them back? A controversial new study says remote work is taking a toll on ...
The prevalence of overweight and obesity represents a global public health challenge 1. Incretin mimetic therapies, including glucagon-like peptide 1 (GLP-1) receptor agonists and dual ...
Postbiotics are gaining momentum. How can ingredient branding support the accessibility of postbiotics in F&B applications?
The incidence of obesity is increasing globally, leading to elevated risk for mortality and comorbidities and increased healthcare costs. GLP-1 RAs that mimic the effects of GLP-1, an incretin hormone ...
A transgender teen tested Roo, Planned Parenthood's AI-powered sexual health chatbot, which includes LGBTQ+ health topics, ...
The risk of cognitive outsourcing is real. But there is reason for optimism, if students are taught good AI habits early and ...
Morning Overview on MSN
A large review argues mental decline isn’t inevitable and the brain can still gain at any age
A systematic review of learning across the adult lifespan, published in Neuroscience and Biobehavioral Reviews, concludes ...
Morning Overview on MSN
An experimental drug doubled one-year survival for pancreatic cancer patients
Patients with metastatic pancreatic cancer who received the experimental drug elraglusib alongside standard chemotherapy saw ...
FDA’s draft “plausible mechanism” framework gives individualized genetic therapies a clearer path to market, but questions remain, write experts at Morrison Foerster.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results